> top > docs > PMC:7441788 > spans > 27433-27723 > annotations

PMC:7441788 / 27433-27723 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T115 123-131 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T116 132-134 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T214 202-204 http://purl.obolibrary.org/obo/CLO_0008426 denotes pg
T215 259-261 http://purl.obolibrary.org/obo/CLO_0008426 denotes pg

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T288 26-31 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T289 68-73 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T290 132-134 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T292 148-153 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T196 0-290 Sentence denotes The fatalities of the HCQ group was significantly lower than no-HCQ group (18.8% vs 47.4%, P < 0.05), and the inflammatory cytokine IL-6 in the HCQ group decreased significantly from 22.2 (8.3 to 118.9 pg/mL) at the beginning of treatment to 5.2 (3.0 to 23.4 pg/mL) at the end of treatment.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
871 132-136 Gene denotes IL-6 Gene:3569
923 22-25 Chemical denotes HCQ MESH:D006886
924 64-67 Chemical denotes HCQ MESH:D006886
925 144-147 Chemical denotes HCQ MESH:D006886

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1258 132-136 Protein denotes IL-6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T114 123-131 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T115 132-134 Body_part denotes IL http://purl.org/sig/ont/fma/fma86578

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
871 132-136 Gene denotes IL-6 Gene:3569
923 22-25 Chemical denotes HCQ MESH:D006886
924 64-67 Chemical denotes HCQ MESH:D006886
925 144-147 Chemical denotes HCQ MESH:D006886

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T196 0-290 Sentence denotes The fatalities of the HCQ group was significantly lower than no-HCQ group (18.8% vs 47.4%, P < 0.05), and the inflammatory cytokine IL-6 in the HCQ group decreased significantly from 22.2 (8.3 to 118.9 pg/mL) at the beginning of treatment to 5.2 (3.0 to 23.4 pg/mL) at the end of treatment.